Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page
Release date: January 30, 2009 Expiration Date: March 1, 2011
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity provides 2 hours (0.2 CEUs) of continuing education credit. Program number 204-000-08-456-H01P.
Accreditation for Nurses
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider #5-115. Program #05-115-09-003. Educational Review Systems is also approved for nursing continuing education by the state of California and the District of Columbia.Accreditation for Nurse Practitioners
This program has been approved for 2.0 contact hours of continuing education (which includes 1.0 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0901011. This program was planned in accordance with AANP CE standards and Policies and AANP Commercial Support Standards.Methods and Format
This is an online activity consisting of audio, presentation slides, post-test, and an activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is 2 hours. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists, nurses, and nurse practitioners in a variety of healthcare settings and the managed care environment, including hospitals, health plans, academia, consulting, medical groups, and employers/purchasers. The program would be beneficial for those who have an interest in cardiology and pharmacy benefits management.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
After participating in this educational activity, participants should be able to
- Identify and explain the key managed-care challenges associated with the management of patients with ACS.
- Discuss the study design and results of recently released clinical trials related to new recommendations in the focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (STEMI).
- Explain the implications of these new evidence-based therapeutic recommendations on patient management.
- Incorporate the recommendations for antiplatelet and anticoagulant therapy in the focused update of the ACC/AHA guidelines for the management of patients with STEMI into benefit designs.
Faculty
Randall Seifert, Pharm.D.
Program Chair and Moderator
Senior Associate Dean and Professor
University of Minnesota, Duluth
School of Pharmacy
Duluth, Minnesota
Michael B. Bottorff, Pharm. D., FCCP, CLS
Professor of Clinical Pharmacy
University of Cincinnati
School of Pharmacy
Cincinnati, Ohio
Michael P. Gulseth, Pharm.D., BCPS
Program Director for Anticoagulation Services
Sanford-USD Medical Center
Sioux Falls, South Dakota
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity
The faculty and planners report the following relationships:Randall Seifert, Pharm.D., reports that he has no relationships pertinent to this activity.
Michael B. Bottorff, Pharm. D., FCCP, CLS, declares that he has served on the speaker’s bureau for Astra-Zeneca, Pfizer, and sanofi-aventis.
Michael P. Gulseth, Pharm.D., BCPS, reports that he has served as a consultant for GlaxoSmithKline.
Activity Planner, Catherine N. Klein, R.Ph., declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S. and the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.
Launch Presentation*
Medical Management of Acute Coronary Syndrome: A Classic Case 
Managing Patients with Acute Coronary Syndrome: Challenges for Managed Care (35 minutes) 
Incorporating New Antiplatelet and Anticoagulation Therapy Recommendations *Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
